{"id":4257,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"1999-07-23","marketCap":14387.2,"name":"Biomarin Pharmaceutical Inc","phone":"14155066700","outstanding":189.88,"symbol":"BMRN","website":"https://www.biomarin.com/","industry":"Biotechnology"},"price":91.16125,"year":2024,"month":8,"day":20,"weekday":"Tuesday","title":"Headwinds and Tailwinds for Biomarin Pharmaceutical Inc Stock","date":"2024-08-20","url":"/posts/2024/08/20/BMRN","content":[{"section":"Headwinds - Potential Challenges","text":"1. Patent Expirations: Biomarin has several patents set to expire in the next few years, which could lead to increased competition from generic drug companies. This may result in a decline in sales and profitability."},{"section":"2. Pricing Pressure: The pharmaceutical industry is facing increasing scrutiny and pressure to lower drug prices. This could impact Biomarin's ability to maintain high pricing for its products, potentially impacting its revenue and profitability.","text":""},{"section":"3. Regulatory Challenges: The regulatory environment for pharmaceutical companies is complex and subject to change. Biomarin may face hurdles in obtaining approvals for its pipeline drugs, which could delay their commercialization and revenue generation.","text":""},{"section":"Tailwinds - Potential Opportunities","text":"1. Strong Pipeline: Biomarin has a robust pipeline of potential drugs in various stages of development. If successfully brought to market, these drugs could generate significant revenue and drive future growth for the company."},{"section":"2. Rare Disease Focus: Biomarin specializes in developing therapies for rare genetic diseases. This niche focus allows the company to target a less crowded market and enjoy pricing power for its specialized drugs, potentially leading to higher profitability.","text":""},{"section":"3. Strategic Partnerships: Biomarin has formed strategic partnerships with larger pharmaceutical companies, such as Pfizer and Roche, which provide financial and commercialization support. These partnerships enhance Biomarin's ability to bring its drugs to market and expand its reach.","text":""},{"section":"4. Increasing R\u0026D Investments: Biomarin continues to invest heavily in research and development to advance its pipeline. This commitment to innovation and scientific progress positions the company for future success and expansion.","text":""},{"section":"Conclusion","text":"While Biomarin Pharmaceutical Inc faces headwinds in the form of patent expirations, pricing pressure, and regulatory challenges, the company also benefits from tailwinds such as a strong pipeline, a rare disease focus, strategic partnerships, and increasing R\u0026D investments. Considering both the potential challenges and opportunities, a balanced assessment suggests that Biomarin has the potential for future growth and success, but careful monitoring of the headwinds is necessary."}],"tags":["LongSignals","Long","Biotechnology"],"news":[{"category":"company","date":1724072400,"headline":"BioMarin to Host 2024 Investor Day on September 4th in New York","id":129444210,"image":"https://media.zenfs.com/en/prnewswire.com/db94610f2d68c7fd655942d2889db5d2","symbol":"BMRN","publisher":"Yahoo","summary":"BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host an Investor Day with financial analysts and institutional investors on Wednesday, September 4, 2024, in New York City from 10:30 am to 1:00 pm Eastern Time. The event will feature presentations from members of the executive management team and will highlight BioMarin's pipeline, strategic plans, growth opportunities and long-term financial outlook.","url":"https://finance.yahoo.com/news/biomarin-host-2024-investor-day-130000802.html"},{"category":"company","date":1723720740,"headline":"Tyra Biosciences a new overweight at Piper Sandler as 'next gen FGFR company'","id":129384596,"image":"","symbol":"BMRN","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3601851925"},{"category":"company","date":1723559640,"headline":"Here's Why You Should Invest in BioMarin (BMRN) Stock Now","id":129336822,"image":"https://media.zenfs.com/en/zacks.com/90c6165961c32b679207868449ac44ae","symbol":"BMRN","publisher":"Yahoo","summary":"Here, we are discussing some reasons why investing in BioMarin (BMRN) stock now may turn out to be a prudent move.","url":"https://finance.yahoo.com/news/heres-why-invest-biomarin-bmrn-143400026.html"},{"category":"company","date":1723557011,"headline":"Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term","id":129336823,"image":"https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83","symbol":"BMRN","publisher":"Yahoo","summary":"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.","url":"https://finance.yahoo.com/news/why-biomarin-pharmaceutical-bmrn-top-135011855.html"},{"category":"company","date":1723547107,"headline":"3 US Stocks That May Be Undervalued According To Estimates","id":129331885,"image":"https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","symbol":"BMRN","publisher":"Yahoo","summary":"As the U.S. stock market stabilizes following a turbulent week, investors are closely monitoring upcoming economic data releases and Federal Reserve comments for further direction. Amid this cautious environment, identifying undervalued stocks can be crucial for those looking to capitalize on potential market opportunities. In this article, we will explore three U.S. stocks that may be undervalued according to estimates, offering insights into why these companies could present attractive...","url":"https://finance.yahoo.com/news/3-us-stocks-may-undervalued-110507339.html"},{"category":"company","date":1723522740,"headline":"Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV), BioMarin Pharmaceutical (BMRN) and Maravai Lifesciences Holdings (MRVI)","id":129331017,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3598522162"},{"category":"company","date":1723522260,"headline":"Optimistic Outlook for BioMarin: Strong Q2 Performance and Strategic Focus Justify Buy Rating","id":129331018,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3598517423"},{"category":"company","date":1723481112,"headline":"BioMarin (BMRN) is an Incredible Growth Stock: 3 Reasons Why","id":129322045,"image":"https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9","symbol":"BMRN","publisher":"Yahoo","summary":"BioMarin (BMRN) could produce exceptional returns because of its solid growth attributes.","url":"https://finance.yahoo.com/news/biomarin-bmrn-incredible-growth-stock-164512949.html"},{"category":"company","date":1723470311,"headline":"Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick","id":129322046,"image":"https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2","symbol":"BMRN","publisher":"Yahoo","summary":"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.","url":"https://finance.yahoo.com/news/growth-investor-1-stock-could-134511319.html"},{"category":"company","date":1723253700,"headline":"Piper lists eight defensive biotechs to face market volatility","id":129290857,"image":"","symbol":"BMRN","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3595678300"},{"category":"company","date":1723209331,"headline":"BioMarin Pharmaceutical Inc (BMRN): Are Hedge Funds Bullish on This Elliott Management-Approved Stock Now?","id":129271992,"image":"https://s.yimg.com/ny/api/res/1.2/KiB13TS.Tr9o9.x2ioCgvQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/1fbba2dc0e7772b46aa04252cd70ae43","symbol":"BMRN","publisher":"Yahoo","summary":"We recently compiled a list of the Top 10 Stock Picks of Elliott Management. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc (NASDAQ:BMRN) stands against Elliott Management’s other stock picks. It was arguably one of the best years for hedge funds, going by the $67 billion returned to […]","url":"https://finance.yahoo.com/news/biomarin-pharmaceutical-inc-bmrn-hedge-131531170.html"},{"category":"company","date":1723111980,"headline":"Biotech Alert: Searches spiking for these stocks today","id":129233683,"image":"","symbol":"BMRN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3592098860"},{"category":"company","date":1723034100,"headline":"$1000 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today","id":129223696,"image":"","symbol":"BMRN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3590310108"},{"category":"company","date":1723033860,"headline":"Balanced Outlook: BioMarin Pharmaceutical’s Strong Q2 Performance Amid Long-Term Uncertainties","id":129223698,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3589583175"},{"category":"company","date":1723033860,"headline":"Buy Rating Affirmed for BioMarin Pharmaceutical Amid Strong Q2 Performance and Strategic Growth Initiatives","id":129223697,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3589583173"},{"category":"company","date":1723025479,"headline":"BioMarin Pharmaceutical Second Quarter 2024 Earnings: Beats Expectations","id":129200275,"image":"https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","symbol":"BMRN","publisher":"Yahoo","summary":"BioMarin Pharmaceutical ( NASDAQ:BMRN ) Second Quarter 2024 Results Key Financial Results Revenue: US$712.0m (up 20...","url":"https://finance.yahoo.com/news/biomarin-pharmaceutical-second-quarter-2024-101119321.html"},{"category":"company","date":1722969754,"headline":"When Product Launches Struggle, Biotech Investors Reward Cost Cuts","id":129185962,"image":"https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8","symbol":"BMRN","publisher":"Yahoo","summary":"Investors are rewarding biotech companies that can trim the fat these days.  Moderna and BioMarin have both been out of favor with investors for a while now.  Both are innovative, midsize biotech companies whose stock prices are in the red over the past year due to the slow uptake of new products.","url":"https://finance.yahoo.com/m/baf184c2-ebf7-3ee4-b9b9-7ca4b4ae5eb0/when-product-launches.html"},{"category":"company","date":1722965758,"headline":"Q2 2024 Biomarin Pharmaceutical Inc Earnings Call","id":129185963,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"BMRN","publisher":"Yahoo","summary":"Q2 2024 Biomarin Pharmaceutical Inc Earnings Call","url":"https://finance.yahoo.com/news/q2-2024-biomarin-pharmaceutical-inc-173558979.html"},{"category":"company","date":1722960194,"headline":"BioMarin Pharmaceutical Reports Strong Q2 Driven by Voxzogo Sales, RBC Says","id":129185964,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"BMRN","publisher":"Yahoo","summary":"BioMarin Pharmaceutical Reports Strong Q2 Driven by Voxzogo Sales, RBC Says","url":"https://finance.yahoo.com/news/biomarin-pharmaceutical-reports-strong-q2-160314382.html"},{"category":"company","date":1722954900,"headline":"BioMarin (BMRN) Q2 Earnings \u0026 Sales Top Estimates, Ups '24 View","id":129185965,"image":"https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","symbol":"BMRN","publisher":"Yahoo","summary":"BioMarin (BMRN) posts better-than-expected second quarter earnings. It also raises its revenue and earnings guidance for full-year 2024.","url":"https://finance.yahoo.com/news/biomarin-bmrn-q2-earnings-sales-143500080.html"},{"category":"company","date":1722947340,"headline":"CSX, Caterpillar rise; ZoomInfo, Teradata fall, Tuesday, 8/6/2024","id":129183922,"image":"","symbol":"BMRN","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=o108x64evq"},{"category":"company","date":1722944700,"headline":"BioMarin pares Roctavian spending as it narrows sales focus","id":129185966,"image":"https://www.biopharmadive.com/imgproxy/FQHIhDqYasPARecpX4lajV2H2BYD8gXitDM-5u7gzDc/g:nowe:0:135/c:756:427/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL2Jpb21hcmluMi5wbmc=.webp","symbol":"BMRN","publisher":"Yahoo","summary":"The company plans to limit sales of the hemophilia gene therapy to the U.S., Italy and Germany, while ending most clinical development work.","url":"https://www.biopharmadive.com/news/biomarin-roctavian-limit-sales-us-germany-italy-hemophilia/723402/"},{"category":"company","date":1722941460,"headline":"Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday","id":129175085,"image":"","symbol":"BMRN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588370461"},{"category":"company","date":1722931440,"headline":"Scotiabank Sticks to Their Hold Rating for BioMarin Pharmaceutical (BMRN)","id":129181113,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588150104"},{"category":"company","date":1722930840,"headline":"BioMarin price target raised by $1 at Scotiabank, here's why","id":129181114,"image":"","symbol":"BMRN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588136387"},{"category":"company","date":1722930780,"headline":"Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Elevation Oncology (ELEV) and Harmony Biosciences Holdings (HRMY)","id":129174905,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588135145"},{"category":"company","date":1722930720,"headline":"Strong Buy on BioMarin: Voxzogo Success and Promising Financial Trajectory","id":129181117,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588133908"},{"category":"company","date":1722930180,"headline":"Biomarin Pharmaceutical Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Results","id":129181118,"image":"","symbol":"BMRN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588120566"},{"category":"company","date":1722929520,"headline":"BioMarin price target raised by $4 at Canaccord, here's why","id":129181119,"image":"","symbol":"BMRN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588108387"},{"category":"company","date":1722929220,"headline":"Evercore ISI Sticks to Its Buy Rating for BioMarin Pharmaceutical (BMRN)","id":129181120,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588100177"},{"category":"company","date":1722927420,"headline":"BioMarin price target raised by $2 at Evercore ISI, here's why","id":129181121,"image":"","symbol":"BMRN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588063513"},{"category":"company","date":1722926760,"headline":"Oppenheimer Remains a Hold on BioMarin Pharmaceutical (BMRN)","id":129181122,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588051901"},{"category":"company","date":1722926700,"headline":"Buy Rating Justified by BioMarin’s Strong Financials and Strategic Market Positioning","id":129181123,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588050702"},{"category":"company","date":1722925500,"headline":"Piper Sandler Sticks to Their Buy Rating for BioMarin Pharmaceutical (BMRN)","id":129181124,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588030783"},{"category":"company","date":1722925020,"headline":"BioMarin price target lowered by $5 at TD Cowen, here's why","id":129181125,"image":"","symbol":"BMRN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588025029"},{"category":"company","date":1722924840,"headline":"Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and C4 Therapeutics (CCCC)","id":129181126,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588020502"},{"category":"company","date":1722924780,"headline":"Buy Rating Affirmed: BioMarin’s Growth and Cost-Management Strategies Signal Strong Market Position","id":129181127,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588019598"},{"category":"company","date":1722923340,"headline":"BioMarin Pharmaceutical (BMRN) Gets a Hold from RBC Capital","id":129181128,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3587999570"},{"category":"company","date":1722922920,"headline":"BioMarin price target raised by $4 at Stifel, here's why","id":129181129,"image":"","symbol":"BMRN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3587993889"},{"category":"company","date":1722919800,"headline":"Barclays Keeps Their Buy Rating on BioMarin Pharmaceutical (BMRN)","id":129181130,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3587953875"},{"category":"company","date":1722918780,"headline":"BioMarin price target lowered by $1 at Barclays, here's why","id":129181132,"image":"","symbol":"BMRN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3587943481"},{"category":"company","date":1722918540,"headline":"BioMarin Pharmaceutical: A Strong Buy on Beat and Raise Results and Strategic Cost Management","id":129181133,"image":"","symbol":"BMRN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3587939506"},{"category":"company","date":1722912480,"headline":"Notable Tuesday Option Activity: BMRN, HRB, BAX","id":129181134,"image":"","symbol":"BMRN","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588688941"},{"category":"company","date":1722906180,"headline":"Biomarin Pharmaceutical Inc (BMRN) Q2 2024 Earnings Call Transcript Highlights: Record Revenue ...","id":129181135,"image":"","symbol":"BMRN","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3587816012"}]}